PD-1/PD-L1-IN-23
Modify Date: 2024-01-11 22:21:45
PD-1/PD-L1-IN-23 structure
|
Common Name | PD-1/PD-L1-IN-23 | ||
|---|---|---|---|---|
| CAS Number | 2597056-04-5 | Molecular Weight | 703.41 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C32H30BrCl2N3O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PD-1/PD-L1-IN-23PD-1/PD-L1-IN-23 is a potent and orally active inhibitor of PD-1/PD-L1. PD-1/PD-L1-IN-23 is an ester prodrug of L7. L7 is a benzo[c][1,2,5]oxadiazole derivative and biologically evaluated as inhibitors of PD-L1. PD-1/PD-L1-IN-23 displays significant antitumor effects in tumor models of syngeneic and PD-L1 humanized mice[1]. |
| Name | PD-1/PD-L1-IN-23 |
|---|
| Description | PD-1/PD-L1-IN-23 is a potent and orally active inhibitor of PD-1/PD-L1. PD-1/PD-L1-IN-23 is an ester prodrug of L7. L7 is a benzo[c][1,2,5]oxadiazole derivative and biologically evaluated as inhibitors of PD-L1. PD-1/PD-L1-IN-23 displays significant antitumor effects in tumor models of syngeneic and PD-L1 humanized mice[1]. |
|---|---|
| Related Catalog | |
| Target |
PD-1/PD-L1[1] |
| References |
| Molecular Formula | C32H30BrCl2N3O6 |
|---|---|
| Molecular Weight | 703.41 |